tetano
Editor, Senior Moderator
Cureus
. 2022 Jul 14;14(7):e26845.
doi: 10.7759/cureus.26845. eCollection 2022 Jul.
COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature
Roxanne T Aleman[SUP] 1 [/SUP], Julia Rauch[SUP] 2 [/SUP], Janvi Desai[SUP] 3 [/SUP], Joumana T Chaiban[SUP] 4 [/SUP]
Affiliations
Abstract
The unpredictability of the coronavirus disease 2019 (COVID-19) pandemic has created an ongoing global healthcare crisis. Implementation of a mass vaccination program to accelerate disease control remains in progress. Although injection site soreness, fatigue, and fever are the most common adverse reactions reported after a COVID-19 vaccination, ipsilateral lymph node enlargement has increasingly been observed. In patients undergoing routine screening and surveillance for breast cancer, interpreting lymphadenopathy (LAP) is challenging in the setting of a recent COVID-19 vaccination. With a growing proportion of the population receiving the vaccine, a multifaceted approach is necessary to avoid unnecessary and costly workup. In this comprehensive review, we summarize the existing literature on COVID-19 vaccine-associated LAP in breast imaging patients.
Keywords: adenopathy; breast cancer detection; breast screening; covid-19; covid-19 vaccine; covid-19 vaccine side effects; covid-19 vaccine-associated lymphadenopthy; lymph nodes; reactive lymphadenopathy; screening mammogram.
. 2022 Jul 14;14(7):e26845.
doi: 10.7759/cureus.26845. eCollection 2022 Jul.
COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature
Roxanne T Aleman[SUP] 1 [/SUP], Julia Rauch[SUP] 2 [/SUP], Janvi Desai[SUP] 3 [/SUP], Joumana T Chaiban[SUP] 4 [/SUP]
Affiliations
- PMID: 35974844
- PMCID: PMC9375123
- DOI: 10.7759/cureus.26845
Abstract
The unpredictability of the coronavirus disease 2019 (COVID-19) pandemic has created an ongoing global healthcare crisis. Implementation of a mass vaccination program to accelerate disease control remains in progress. Although injection site soreness, fatigue, and fever are the most common adverse reactions reported after a COVID-19 vaccination, ipsilateral lymph node enlargement has increasingly been observed. In patients undergoing routine screening and surveillance for breast cancer, interpreting lymphadenopathy (LAP) is challenging in the setting of a recent COVID-19 vaccination. With a growing proportion of the population receiving the vaccine, a multifaceted approach is necessary to avoid unnecessary and costly workup. In this comprehensive review, we summarize the existing literature on COVID-19 vaccine-associated LAP in breast imaging patients.
Keywords: adenopathy; breast cancer detection; breast screening; covid-19; covid-19 vaccine; covid-19 vaccine side effects; covid-19 vaccine-associated lymphadenopthy; lymph nodes; reactive lymphadenopathy; screening mammogram.